Search clinical trials for: ACE527

Total 9 results

TD Vaccines A/S
Johns Hopkins Bloomberg School of Public Health; Pierrel Research USA, Inc.

Completed

Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea

Diarrhea

United States
TD Vaccines A/S
Johns Hopkins University; Pierrel Research USA, Inc.

Completed

ACE527 Safety and Immunogenicity Study

Enterotoxigenic E. Coli (ETEC) Infection

United States
PATH

Completed

Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults

Diarrhea

United States
Chongqing Public Health Medical Center
Zhejiang Qixin Biotech; Chongqing Sidemu Biotech

Unknown

A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19

COVID-19

China
Mahmoud Ramadan mohamed Elkazzaz

Not yet recruiting

CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

COVID-19 Respiratory Infection
Kafrelsheikh University
Foshan University Laboratory of Emerging Infectious Disease Institute of...

Not yet recruiting

Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2 (Bacterial ACE2)

COVID-19
University of Pennsylvania

Not yet recruiting

ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)

SARS-CoV-2

United States
Universidad Francisco de Vitoria
Universidad Rey Juan Carlos

Completed

Physiotherapy for Persistent COVID-19 Disease Using Aerobic Exercise

COVID-19 | Genetic Predisposition to Disease

Spain
Kafrelsheikh University

Not yet recruiting

Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications

COVID

3

Subscribe